JPRN-jRCTs051210205招募中1 期
Development of a new diagnostic method for pancreatic cancer using 13C-labeled glucose-derived metabolites: a single-arm, exploratory clinical study
Tobimatsu Kazutoshi0 个研究点目标入组 60 人开始时间: 2022年3月25日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 80age old（—）
- 性别
- All
入选标准
- •1. Age over 20, under 80
- •2. Diagnosed patients of pancreatic cancer, benigh pancreatic disease or other gastroenterological cancer
- •3. Patients who have given their free and written consent to participate in this clinical research.
排除标准
- •1. ECOG-PS 4, or patients who have difficulty urinating or collecting urine on their own
- •2. Patients deemed inappropriate by the attending doctor
研究者
相似试验
已完成
不适用
Developing a diagnostic method for pancreatic cancer at the very early stageIntraductal papillary mucinous neoplasm (IPMN), Pancreatic cancerJPRN-UMIN000017958Osaka City University100
已完成
不适用
Innovation of new diagnostic modalities for pancreatic cancer using PET-MRIpancreatic cancerJPRN-UMIN000016679Fukushima Medical University30
招募中
不适用
Diagnosis of Pancreatic Cancer by Purine Metabolite (Hypoxanthine, Xanthine) in UrinePancreas CancerDiagnosisNCT06291779Ho-Seong Han120
招募中
不适用
Project for detection of pancreatic cancer at an early stage with curative surgery in Osaka cityJPRN-UMIN000026915Tazuke Kofukai Medical Research Institute, Kitano Hospital400
已完成
不适用
Development of cytological analysis of pancreatic cancer using homology technologypancreatic cancerJPRN-UMIN000044462Mie University180